Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

Dumessa Edessa,1 Mekonnen Sisay2 1Department of Pharmacy Practice, 2Department of Pharmacology and Toxicology, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Oromia, Ethiopia Abstract: In normal cell cycle progression, transition of G0/G1 phase to synthesis (S) phas...

Full description

Saved in:
Bibliographic Details
Main Authors: Edessa D, Sisay M
Format: article
Language:EN
Published: Dove Medical Press 2017
Subjects:
Online Access:https://doaj.org/article/adb89baa8dbc4a39a078e6ab110d38ab
Tags: Add Tag
No Tags, Be the first to tag this record!